Test Code VZIKU Zika Virus, PCR, Molecular Detection, Random, Urine
Ordering Guidance
Due to similar clinical presentations, testing for RNA or IgM-class antibodies to dengue and chikungunya viruses, concurrently with Zika virus testing, is strongly recommended.
Additional Testing Requirements
The US Food and Drug Administration requires that urine specimens be tested in conjunction with a paired serum specimen; order VZIKS / Zika Virus, PCR, Molecular Detection, Serum for the paired serum specimen.
Specimen Required
Container/Tube: Sterile container
Specimen Volume: 1 mL
Collection Instructions:
1. Collect random urine in a sterile container.
2. Label specimen as urine.
Useful For
Qualitative detection of Zika virus RNA in paired urine and serum from individuals meeting the Centers of Disease Control and Prevention Zika virus clinical or epidemiologic criteria
Testing Algorithm
Due to US Food and Drug Administration requirements, urine specimens must be tested in conjunction with a paired serum specimen. See Additional Testing Requirements
The following algorithms are available:
Special Instructions
Method Name
Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR)/DNA Probe Hybridization
Reporting Name
Zika Virus PCR, UrineSpecimen Type
UrineSpecimen Minimum Volume
0.3 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Urine | Refrigerated (preferred) | 7 days | |
Frozen | 7 days |
Reject Due To
Other | Urine containing preservatives |
Reference Values
Negative
Reference values apply to all ages.
Interpretation
A positive test result indicates the presence of Zika virus RNA in the specimen. The FDA requires that urine specimens be tested in conjunction with a paired serum specimen. However, a positive result in either specimen is consistent with recent infection.
A negative test result with a positive internal control indicates that Zika virus RNA is not detectable in the specimen.
A negative test result with a negative internal control is considered evidence of polymerase chain reaction inhibition or reagent failure. A new specimen should be collected for testing if clinically indicated.
Day(s) Performed
Tuesday, Thursday
Report Available
Same day/1 to 5 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test has received Emergency Use Authorization (EUA) by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
87662
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
VZIKU | Zika Virus PCR, Urine | 85623-7 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
619458 | Zika Urine PCR Result | 85623-7 |
619459 | Zika Urine PCR Interpretation | 69048-7 |
Forms
If not ordering electronically, complete, print, and send a Microbiology Test Request (T244) with the specimen.